MedAvail Holdings, Inc.
MDVLDelisted Mar 21, 2024- Industry
- Retail-Drug Stores and Proprietary Stores
- SEC CIK
- 0001402479
MedAvail Holdings, Inc. was delisted on Mar 21, 2024; its insiders filed their last Form 4 on Feb 6, 2024; 21 institutions reported holding it in 13F filings for Q4 2023, worth $6.16M in total; no superinvestor held it.
13F holders, Q1 2024
Institutional positions in MedAvail Holdings, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
MDVL is no longer listed, and 13F filings after Q4 2023 list far fewer holders. See Q4 2023
- Institutional holders
- 1
- −20 vs. Q4 2023
- Shares held
- 47.8K
- −1.32M (−96.5%) vs. Q4 2023
- Total value
- $0
- −$6.16M (−100.0%) vs. Q4 2023
- New holders
- 0
- 0 more added
- Sold out
- 20
- 0 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MDVL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 1 | $0 |
| Q4 2024 | 1 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 1 | $0 |
| Q4 2023 | 21 | $6.16M |
| Q3 2023 | 19 | $8.08M |
| Q2 2023 | 27 | $16.5M |
| Q1 2023 | 27 | $19.5M |
| Q4 2022 | 32 | $20.6M |
| Q3 2022 | 33 | $53.9M |
| Q2 2022 | 40 | $92.8M |
| Q1 2022 | 50 | $30.0M |
| Q4 2021 | 53 | $36.8M |
| Q3 2021 | 49 | $78.5M |
| Q2 2021 | 45 | $348.1M |
| Q1 2021 | 34 | $372.4M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding MedAvail Holdings, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Cigna Investments Inc | 47,789 | $0 | 0.00% | 00.0% | Unchanged |
| Redmile Group, LLC | 0 | $0 | 0.00% | −692,082−100.0% | Sold out |
| ABG-WTT Global Life Science Capital Partners GP Ltd | 0 | $0 | 0.00% | −300,588−100.0% | Sold out |
| Ally Bridge Group (NY) LLC | 0 | $0 | 0.00% | −117,897−100.0% | Sold out |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −87,618−100.0% | Sold out |
| Pura Vida Investments, LLC | 0 | $0 | 0.00% | −58,070−100.0% | Sold out |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −16,732−100.0% | Sold out |
| Vanguard Group Inc | 0 | $0 | 0.00% | −14,031−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −10,618−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −2,050−100.0% | Sold out |
| BlackRock Inc. | 0 | $0 | 0.00% | −1,643−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −430−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −263−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −185−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −121−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −98−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −54−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −13−100.0% | Sold out |
| Global Retirement Partners, LLC | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −9−100.0% | Sold out |